Next Generation Sequencing Claims in Precision Medicine: Questions a Formulary Committee Should Ask
The enthusiasm with which precision medicine has been embraced over the past 15 years has obscured the fact that the evidence base for biomarker-driven assessments, in particular for next generation sequencing (NGS), is limited. This applies both to the comparative performance of the various assess...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Minnesota Libraries Publishing
2016-11-01
|
| Series: | INNOVATIONS in Pharmacy |
| Subjects: | |
| Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/473 |